*Aged

The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 
Breast cancer screening in older women: overview, Journal of gerontology (1992)
 

*Aging

Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 

*Aminoglycosides

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

*Antineoplastic Agents

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 

*Attitude to Health

Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 

*Breast Self-Examination

Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 

*Carcinoembryonic Antigen

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

*Centers for Disease Control and Prevention (U.S.)

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

*Child Guidance

*Clinical Competence

A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 

*Community Health Centers

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 

*Community Health Services

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

*Counseling

Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 

*Curriculum

Design, implementation, and evaluation of a longitudinal cancer curriculum (with Victoria P. Gaw), Journal of cancer education : the official journal of the American Association for Cancer Education (1987)

The University of Massachusetts Medical School's two year preclinical curriculum is organized by organ system...

 

*Education, Continuing

A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 

*Education, Medical, Continuing

Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 

*Family

*Family Practice

Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 

*Genetic Predisposition to Disease

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 

*Government Programs

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

*Health Education

The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 

*Health Knowledge, Attitudes, Practice

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 

*Health Services Accessibility

Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 

*Hodgkin Disease

Hodgkin's disease in the elderly (with F. P. Li, J. Lokich, W. C. Moloney, and S. Hellman), Lancet (1973)
 

*Leadership

Women in medical leadership, Journal of the American Medical Women's Association (1972) (1989)
 

*Mammography

The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 

*Mass Media

Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

*Mass Screening

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 
Breast cancer screening in older women: overview, Journal of gerontology (1992)
 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

*Mediastinal Neoplasms

Hodgkin's disease in the elderly (with F. P. Li, J. Lokich, W. C. Moloney, and S. Hellman), Lancet (1973)
 

*Medicare

The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 

*Models, Theoretical

Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 

*Motivation

Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 

*Palpation

The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 

*Patient Acceptance of Health Care

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 

*Patient Compliance

Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 

*Patient Simulation

The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 

*Perception

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 

*Physical Examination

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 

*Physician's Practice Patterns

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 

*Physician's Role

Women in medical leadership, Journal of the American Medical Women's Association (1972) (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 

*Physicians, Women

Women in medical leadership, Journal of the American Medical Women's Association (1972) (1989)
 

*Practice Guidelines

Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

*Primary Health Care

Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 

*Radiology

Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 

*Reminder Systems

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

*Role

Women in medical leadership, Journal of the American Medical Women's Association (1972) (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 

*Telephone

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 

*Thigh

Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

*Transplantation Immunology

Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 

*Women's Health

Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 

Acetylation

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Acute Disease

Adenocarcinoma

A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Adenoma, Islet Cell

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Adjuvants, Pharmaceutic

The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Adolescent

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Hodgkin's disease in the elderly (with F. P. Li, J. Lokich, W. C. Moloney, and S. Hellman), Lancet (1973)
 

Adult

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Hodgkin's disease in the elderly (with F. P. Li, J. Lokich, W. C. Moloney, and S. Hellman), Lancet (1973)
 
Munchausen syndrome--further follow-up (with M. J. Lynch and M. Kasakian), The New England journal of medicine (1972)
 

African Americans

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Age Factors

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
Hodgkin's disease in the elderly (with F. P. Li, J. Lokich, W. C. Moloney, and S. Hellman), Lancet (1973)
 

Aged

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Aged, 80 and over

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 

Aging

Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Algorithms

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Alkaline Phosphatase

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Alpha-Globulins

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Altretamine

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 

American Cancer Society

Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 

Amides

Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Aminoglutethimide

The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Analysis of Variance

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

Animals

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Anthracyclines

Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 

Anti-Bacterial Agents

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

Antibiotics, Antineoplastic

Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 

Antibodies, Neoplasm

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Antigen-Antibody Complex

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Antigens, Neoplasm

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Antigens, Viral

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Antineoplastic Agents

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Letter: Chemotherapy of breast cancer, The New England journal of medicine (1976)
 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Antineoplastic Combined Chemotherapy Protocols

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 
Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 

Appalachian Region

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Attitude of Health Personnel

Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 

Attitude to Health

Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 

Basement Membrane

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

BCG Vaccine

Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 

Biopsy

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Biopsy, Needle

Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Bleomycin

Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Bone Marrow

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Brain Neoplasms

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

Breast

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 

Breast Neoplasms

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
Breast cancer screening in older women: overview, Journal of gerontology (1992)
 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 
Breast cancer screening and primary care providers (with Jane G. Zapka and H. L. Greene Jr.), Progress in clinical and biological research (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 
Preliminary report of an intervention to improve mammography skills of radiologists (with C. J. D'Orsi, A. Karellas, and Victoria P. Gaw), Progress in clinical and biological research (1989)
 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 
Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 
Letter: Chemotherapy of breast cancer, The New England journal of medicine (1976)
 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 

Breast Self-Examination

Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

Bronchiolitis, Viral

Carboplatin

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 

Carcinoembryonic Antigen

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Carcinogens

Carcinoma

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 

Carcinoma, Basal Cell

Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Carcinoma, Hepatocellular

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Carcinoma, Non-Small-Cell Lung

Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 

Carmustine

Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Castration

The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Cell Membrane

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Cell Transformation, Neoplastic

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Chi-Square Distribution

Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 

Child

Child Behavior Disorders

Child, Hospitalized

Child, Preschool

Cisplatin

Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 

Clinical Competence

The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 

Clinical Protocols

Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 

Clinical Trials

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 

Clinical Trials, Phase II

Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 

Collagen Diseases

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Colonic Neoplasms

Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Colonic Polyps

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 

Colorado

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Colorectal Neoplasms

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Combined Modality Therapy

Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 

Community Health Centers

Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 

Community Health Services

Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 

Complement System Proteins

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Computer-Assisted Instruction

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Continental Population Groups

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Cost-Benefit Analysis

Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 

Costs and Cost Analysis

Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 

Counseling

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 

Cricetinae

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Cross-Sectional Studies

The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 

Cyclophosphamide

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Cystadenocarcinoma

Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 

Cytoplasm

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Dacarbazine

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 

Data Collection

Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 

Decision Making

Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 

Decision Support Techniques

Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 

Decision Trees

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Demography

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 

Diagnosis, Differential

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Diagnostic Errors

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Diagnostic Imaging

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 

Diarrhea

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Digestive System

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Doxorubicin

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 

Drug Administration Schedule

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 

Drug Evaluation

Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 

Drug Evaluation, Preclinical

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

Drug Hypersensitivity

Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 

Drug Resistance

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 

Drug Synergism

Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Drug Therapy, Combination

Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Education, Medical, Continuing

The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 

Education, Medical, Undergraduate

Design, implementation, and evaluation of a longitudinal cancer curriculum (with Victoria P. Gaw), Journal of cancer education : the official journal of the American Association for Cancer Education (1987)

The University of Massachusetts Medical School's two year preclinical curriculum is organized by organ system...

 

Educational Status

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 

Effect Modifiers (Epidemiology)

Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 

effects

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 

Electrocardiography

5-Fluorouracil-associated cardiotoxicity (with N. J. Freeman), Cancer (1988)

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil....

 

Employee Performance Appraisal

A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 

Employment

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Empyema

Epitopes

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Europe

Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 

Factor Analysis, Statistical

Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 

Family Practice

The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 

Feasibility Studies

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Female

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
Breast cancer screening in older women: overview, Journal of gerontology (1992)
 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 
Women in medical leadership, Journal of the American Medical Women's Association (1972) (1989)
 
Breast cancer screening and primary care providers (with Jane G. Zapka and H. L. Greene Jr.), Progress in clinical and biological research (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 
Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 
Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Letter: Chemotherapy of breast cancer, The New England journal of medicine (1976)
 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Munchausen syndrome--further follow-up (with M. J. Lynch and M. Kasakian), The New England journal of medicine (1972)
 

Fetal Proteins

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Florida

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Fluorescent Antibody Technique

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Fluorouracil

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
5-Fluorouracil-associated cardiotoxicity (with N. J. Freeman), Cancer (1988)

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil....

 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Folic Acid Antagonists

Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 

Follow-Up Studies

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 
Munchausen syndrome--further follow-up (with M. J. Lynch and M. Kasakian), The New England journal of medicine (1972)
 

Forecasting

Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Gastrointestinal Diseases

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Gastrointestinal Neoplasms

Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 

Genetic Screening

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 

Georgia

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Glioblastoma

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 

Glycoproteins

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Goats

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Guinea Pigs

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Half-Life

Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 

Health Behavior

Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 

Health Care Costs

Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Health Education

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Health Knowledge, Attitudes, Practice

Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 

Health Maintenance Organizations

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 

Health Policy

Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 

Health Promotion

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 

Health Services Accessibility

The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Health Services Needs and Demand

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Health Services Research

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Health Surveys

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 

Heart

5-Fluorouracil-associated cardiotoxicity (with N. J. Freeman), Cancer (1988)

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil....

 

Hematologic Diseases

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 

Hispanic Americans

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 

Humans

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
Breast cancer screening in older women: overview, Journal of gerontology (1992)
 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 
Women in medical leadership, Journal of the American Medical Women's Association (1972) (1989)
 
Breast cancer screening and primary care providers (with Jane G. Zapka and H. L. Greene Jr.), Progress in clinical and biological research (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 
Preliminary report of an intervention to improve mammography skills of radiologists (with C. J. D'Orsi, A. Karellas, and Victoria P. Gaw), Progress in clinical and biological research (1989)
 
5-Fluorouracil-associated cardiotoxicity (with N. J. Freeman), Cancer (1988)

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil....

 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 
Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 
Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 
Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Letter: Chemotherapy of breast cancer, The New England journal of medicine (1976)
 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 
Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 
Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 
Hodgkin's disease in the elderly (with F. P. Li, J. Lokich, W. C. Moloney, and S. Hellman), Lancet (1973)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 
Munchausen syndrome--further follow-up (with M. J. Lynch and M. Kasakian), The New England journal of medicine (1972)
 

Hydroxyurea

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 

Hypokalemia

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Hypophysectomy

The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Imidazoles

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Imides

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Immune Sera

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Immunity, Natural

Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 

Immunoglobulins

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Immunosuppression

Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 

Immunosuppressive Agents

Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 

Incidence

Breast cancer screening in older women: overview, Journal of gerontology (1992)
 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 

Income

The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Infant

Infusions, Intravenous

Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 

Injections, Intravenous

A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 

Inservice Training

Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 

Insurance, Health

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 

Insurance, Health, Reimbursement

The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 

Intervention Studies

The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 

Interviews

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Intestinal Diseases

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Isoenzymes

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Isoquinolines

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Kidney

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Kidney Glomerulus

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Laryngitis

Leukopenia

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Life Expectancy

Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Liver

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Liver Diseases

Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

Liver Neoplasms

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Logistic Models

Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 

Lomustine

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 

Lung Neoplasms

Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Lymph Node Excision

Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Lymphatic Metastasis

Letter: Chemotherapy of breast cancer, The New England journal of medicine (1976)
 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Lymphoma, Non-Hodgkin

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Male

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
5-Fluorouracil-associated cardiotoxicity (with N. J. Freeman), Cancer (1988)

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil....

 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Mammary Neoplasms, Experimental

Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 

Mammography

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 
Breast cancer screening and primary care providers (with Jane G. Zapka and H. L. Greene Jr.), Progress in clinical and biological research (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 
Preliminary report of an intervention to improve mammography skills of radiologists (with C. J. D'Orsi, A. Karellas, and Victoria P. Gaw), Progress in clinical and biological research (1989)
 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 

Marriage

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 

Mass Screening

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 
Breast cancer screening and primary care providers (with Jane G. Zapka and H. L. Greene Jr.), Progress in clinical and biological research (1989)
 
Breast cancer screening for primary care physicians (with H. L. Greene Jr., Jane G. Zapka, R. S. Barth, C. J. D'Orsi, and M. D. Wertheimer), Progress in clinical and biological research (1989)

Our 3 Step Primary Care Program is apparently successful. The first year program focused on...

 
Preliminary report of an intervention to improve mammography skills of radiologists (with C. J. D'Orsi, A. Karellas, and Victoria P. Gaw), Progress in clinical and biological research (1989)
 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 
Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Massachusetts

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 
Design, implementation, and evaluation of a longitudinal cancer curriculum (with Victoria P. Gaw), Journal of cancer education : the official journal of the American Association for Cancer Education (1987)

The University of Massachusetts Medical School's two year preclinical curriculum is organized by organ system...

 

Medical History Taking

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Medical Oncology

Design, implementation, and evaluation of a longitudinal cancer curriculum (with Victoria P. Gaw), Journal of cancer education : the official journal of the American Association for Cancer Education (1987)

The University of Massachusetts Medical School's two year preclinical curriculum is organized by organ system...

 

Medicare Part B

Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

Melanoma

Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Melphalan

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Menopause

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 

Metabolic Clearance Rate

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Metabolic Diseases

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 

Methotrexate

Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 

Mice

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 

Mice, Inbred C3H

Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 

Mice, Nude

Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

Michigan

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Middle Aged

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Screening mammography. When should it stop (with T. Byers and H. Kattlove), Cancer practice (1997)
 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 
The extent of breast cancer screening in older women, Cancer (1994)

Women 65 and older present a unique challenge to health professionals, particularly with respect to...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 
Screening mammography, JAMA : the journal of the American Medical Association (1991)
 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study (with H. Kreisman, M. Goutsou, C. Modeas, S. L. Graziano, and M. R. Green), European journal of cancer (Oxford, England : 1990) (1990)

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal...

 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 
5-Fluorouracil-associated cardiotoxicity (with N. J. Freeman), Cancer (1988)

Cardiotoxicity manifested as myocardial ischemia is not generally recognized as a side effect of 5-fluorouracil....

 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 
Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Milk, Human

Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 

Models, Statistical

Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 

Mother-Child Relations

Motivation

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Multivariate Analysis

Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Munchausen Syndrome

Munchausen syndrome--further follow-up (with M. J. Lynch and M. Kasakian), The New England journal of medicine (1972)
 

Naphthalimides

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Necrosis

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 

Neoplasm Metastasis

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Metastatic basal cell carcinoma: review, report of a case, and chemotherapy (with Y. Dayal, S. Binder, and L. Nathanson), Cancer (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Neoplasm Recurrence, Local

The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Neoplasm Staging

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

Neoplasm Transplantation

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Effects on metastases of drug therapy during developing and established tumor immunity (with J. Vaage), International journal of cancer. Journal international du cancer (1983)

The effectiveness of treatment with cyclophosphamide, methotrexate and 5-fluorouracil was studied during the s.c. and...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

Neoplasms

Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Nephrotic Syndrome

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

New England

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 

New Mexico

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Nitrogen Mustard Compounds

Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 

Nitrosourea Compounds

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

North America

Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 

Odds Ratio

Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 

Outcome and Process Assessment (Health Care)

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Outpatients

A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 

Ovarian Neoplasms

Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 

Paclitaxel

Phase II studies: untreated breast cancer patients, Journal of the National Cancer Institute (1992)
 

Palpation

Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 

Pancreatic Neoplasms

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Patient Acceptance of Health Care

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 

Patient Compliance

Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 

Patient Education

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 

Patient Simulation

Can practicing physicians improve their counseling and physical examination skills in breast cancer screening? A feasibility study (with H. L. Greene Jr., D. McManus, N. E. Hoople, and R. S. Barth), Journal of cancer education : the official journal of the American Association for Cancer Education (1995)

OBJECTIVE. To improve breast cancer screening skills, practicing non-academic primary care physicians were offered an...

 

Pedigree

The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 

Phenylalanine

Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 

Physical Examination

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

Physician's Practice Patterns

Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 

Physician's Role

The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 

Physicians

PDF

Impact of a physician intervention program to increase breast cancer screening (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Robin S. Barth, Victoria P. Gaw, Harry L. Greene, and Anne M. Stoddard), Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (1992)

In order to improve compliance with the National Cancer Institute's breast cancer screening guidelines, we...

 

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 

Physicians, Family

Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Physician compliance with mammography guidelines: barriers and enhancers (with Anne M. Stoddard, Jane G. Zapka, Victoria P. Gaw, and R. S. Barth), The Journal of the American Board of Family Practice / American Board of Family Practice (1992)

BACKGROUND: Primary care physicians are increasingly the gatekeepers to clinical preventive services including mammography utilization....

 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 

Pilot Projects

Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 
A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443 (with Daniel R. Budman, Ann Hughes Korzun, Joseph Aisner, Jerry Younger, Richard Silver, Mary Alice Rice, and William Wood), Cancer investigation (1990)

In preparation for a national Phase III study of dose and dose intensity in the...

 

Placenta

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Platinum

Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 

Pneumonia, Staphylococcal

Practice Guidelines

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Precancerous Conditions

Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 

Preventive Health Services

Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 

Primary Health Care

Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 

Prognosis

Adjuvant chemotherapy. Eight years later, JAMA : the journal of the American Medical Association (1984)
 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

Program Development

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Program Evaluation

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
The effectiveness of using standardized patients to improve community physician skills in mammography counseling and clinical breast exam (with Roger Luckmann, Mark E. Quirk, Lynn Clemow, Mary Jo White, and Anne M. Stoddard), Preventive medicine (1999)

BACKGROUND: Traditional didactic continuing education is relatively ineffective in improving physicians' clinical skills. We hypothesized...

 

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Emphasizing screening activities in a community health center: a case study of a breast cancer screening project (with Jane G. Zapka, L. Chasan, R. S. Barth, and E. Mas), The Journal of ambulatory care management (1991)
 

Proportional Hazards Models

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 

Prospective Studies

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 

Quality Assurance, Health Care

A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 

Quality Control

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 
Feasibility of universal screening mammography. Lessons from a community intervention (with C. J. D'Orsi, H. L. Greene Jr., Victoria P. Gaw, A. Karellas, and Jane G. Zapka), Archives of internal medicine (1991)

It is estimated that 44,500 American women will die of breast cancer in 1991. The...

 

Quality of Life

Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Questionnaires

Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Cancer prevention practices and continuing education needs of primary care physicians (with N. E. Hoople, Victoria P. Gaw, and Anne M. Stoddard), American journal of preventive medicine (1993)

We surveyed 1,500 primary care physicians in Massachusetts regarding their current attitudes and practices, as...

 
Impact of a breast cancer screening community intervention (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Anne M. Stoddard, Robin S. Barth, and Victoria P. Gaw), Preventive medicine (1993)

BACKGROUND. Efforts to detect breast cancer in its early stages are necessary to reduce breast...

 
Breast cancer screening: perceptions and experience of primary care physicians, radiologists and women (with Jane G. Zapka, Anne M. Stoddard, and H. L. Green Jr.), Progress in clinical and biological research (1990)
 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 

Quinazolines

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 

Rabbits

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Radioimmunoassay

Proceedings: Carcinoembryonic antigen. Report of a screening study (with S. Das, L. Nathanson, A. Rule, and R. S. Schwartz), Cancer (1974)
 
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (with V. Pinn, R. S. Schwartz, and L. Nathanson), The New England journal of medicine (1973)
 

Radiology

Preliminary report of an intervention to improve mammography skills of radiologists (with C. J. D'Orsi, A. Karellas, and Victoria P. Gaw), Progress in clinical and biological research (1989)
 

Radiotherapy, High-Energy

Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 

Randomized Controlled Trials

Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 

Receptors, Estrogen

PDF

Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642) (with D Berry, I. C. Henderson, M. J. Ratain, K Wu, C Shapiro, D Duggan, J Kalra, I Berkowitz, and A. P. Lyss), Clinical cancer research : an official journal of the American Association for Cancer Research (1995)

Amonafide is a new imide derivative of naphthalic acid. The drug had demonstrated significant activity...

 
The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Regression Analysis

Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Remission, Spontaneous

Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

Reproducibility of Results

Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 

Research

Breast cancer screening and primary care providers (with Jane G. Zapka and H. L. Greene Jr.), Progress in clinical and biological research (1989)
 

Retrospective Studies

Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy (with T. W. Griffin, A. E. Bogden, S. D. Reich, D. Antonelli, R. E. Hunter, A. Ward, D. T. Yu, and H. L. Greene Jr.), Cancer (1983)

Retrospective and prospective clinical trials were performed to determine the usefulness of the 6-day subrenal...

 

Risk

PDF

Effect of a community health center intervention on breast cancer screening among Hispanic American women (with Jane G. Zapka, Donald R. Harris, David W. Hosmer, Edith Mas, and Robin S. Barth), Health services research (1993)

OBJECTIVE. A multiple component intervention in a community health center is presented, and its effect...

 
Familial colon cancer (with M. S. Miller, F. P. Li, L. Stolbach, R. Stone, and L. Nathanson), Cancer (1976)

Study was made of a kindred with a strong history of carcinoma of the colon....

 

Risk Assessment

Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation (with Mary Jo White, Jennifer Rider Stark, Roger Luckmann, Milagros C. Rosal, and Lynn Clemow), Patient education and counseling (2005)

OBJECTIVE: Computer-assisted telephone interviewing (CATI) systems used by telephone counselors (TCs) may be efficient mechanisms...

 

Risk Factors

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 

PDF

American Cancer Society guidelines for breast cancer screening: update 2003 (with Robert A. Smith, Debbie Saslow, Kimberly Andrews Sawyer, Wylie Burke, W. Phil Evans 3rd, Roger S. Foster Jr., Edward Hendrick, Harmon J. Eyre, and Steven Sener), CA: a cancer journal for clinicians (2003)

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer...

 
Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 

Self Care

Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 

Self-Examination

Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 

Semustine

Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

Sensitivity and Specificity

Breast cancer screening: early recognition (with Kathryn L. Edmiston), Comprehensive therapy (1997)

The epidemic of breast cancer and the availability of tools to increase early detection and...

 

Sepsis

Serum Albumin

Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 

Sibling Relations

Simian virus 40

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Socioeconomic Factors

Factors associated with colorectal cancer risk perception: the role of polyps and family history (with Jennifer Rider Stark, Elizabeth R. Bertone-Johnson, and Anne M. Stoddard), Health education research (2006)

It is unclear how objective risk factors influence the factors associated with colorectal cancer (CRC)...

 
Underutilizers of mammography screening today: characteristics of women planning, undecided about, and not planning a mammogram (with Lynn Clemow, W. P. Haddad, Roger Luckmann, Mary Jo White, D. Klaus, and Anne M. Stoddard), Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2000)

Using concepts from the Precaution Adoption Process Model, we identified behavioral factors, sociodemographic and psychosocial...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
Interval adherence to mammography screening guidelines (with Jane G. Zapka, Anne M. Stoddard, and L. Maul), Medical care (1991)

The objectives of this research were to document adherence to mammography screening guidelines among women...

 

PDF

Breast cancer screening by mammography: utilization and associated factors (with Jane G. Zapka, Anne M. Stoddard, and H. L. Greene Jr.), American journal of public health (1989)

The status of mammography screening experience and factors related to utilization were examined in six...

 

Soft Tissue Neoplasms

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 

Spectrophotometry, Atomic

Doxorubicin and cisplatin excretion into human milk (with P. C. Egan, P. Dodion, M. J. Egorin, and N. R. Bachur), Cancer treatment reports (1985)

Plasma and milk concentrations of doxorubicin (DOX) and cisplatin were measured after iv administration of...

 

Stomach Diseases

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Streptozocin

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Sulfur

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Suppression, Genetic

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Survival Analysis

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 

Survival Rate

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry (with Donald A. Berry, Gloria Broadwater, John P. Klein, Karen Antman, Joseph Aisner, Jacob Bitran, Cesar O. Freytes, Edward Stadtmauer, Robert Peter Gale, I. Craig Henderson, Hillard M. Lazarus, Philip L. McCarthy Jr., Larry Norton, Howard Parnes, Andrew Pecora, Michael C. Perry, Philip Rowlings, Gary Spitzer, and Mary M. Horowitz), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2002)

PURPOSE: To assess survival of patients with metastatic breast cancer treated with high-dose chemotherapy (HDC)...

 
Issues in breast cancer screening in older women, Cancer (1994)

Screening is a way of detecting disease early in an asymptomatic population. For cancer screening...

 

Syndrome

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Tamoxifen

The medical management of breast cancer, Clinical obstetrics and gynecology (1982)
 

Technology Assessment, Biomedical

Clinical breast examination, breast self-examination: what is the evidence for utility in screening for breast cancer, Women's health issues : official publication of the Jacobs Institute of Women's Health (1992)
 

Technology, Radiologic

A program to improve mammography skills of practicing radiologic technologists (with Victoria P. Gaw, S. M. Bush, C. J. D'Orsi, A. Karellas, M. Dowd, and Jane G. Zapka), QRB. Quality review bulletin (1991)

Periodic screening mammography and clinical breast examination have significantly reduced the breast cancer mortality rate...

 

Telephone

A randomized trial of telephone counseling to promote screening mammography in two HMOs (with Roger Luckmann, Judith A. Savageau, Lynn Clemow, and Anne M. Stoddard), Cancer detection and prevention (2003)

Tailored telephone counseling (TTC) is effective in increasing utilization of screening mammography, but has received...

 
Promoting mammography: results of a randomized trial of telephone counseling and a medical practice intervention (with Anne M. Stoddard, Roger Luckmann, Mary Jo White, Jill S. Avrunin, and Lynn Clemow), American journal of preventive medicine (2000)

BACKGROUND: Despite widespread promotion of mammography screening, a distinct minority of women have remained underusers...

 

Texas

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 

Thiotepa

Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary (with W. K. Tak, D. J. Marchant, J. E. Munzenrider, G. W. Mitchel Jr., L. Nathanson, and B. Emami), International journal of radiation oncology, biology, physics (1977)
 

Thrombocytopenia

Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 

Time Factors

American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Supporting statements and rationale (with G. J. Annas, M. L. Brown, C. K. Cassel, V. Champion, H. J. Cohen, P. S. Frame, L. Glasse, V. Mor, and S. G. Pauker), Journal of gerontology (1992)
 
Effects of a news event on breast cancer screening survey responses (with Anne M. Stoddard, Jane G. Zapka, and S. Schoenfeld), Progress in clinical and biological research (1990)
 
Increasing the effort toward breast cancer detection (with M. D. Wertheimer, T. F. Dodson, C. J. D'Orsi, H. Pastides, and Jane G. Zapka), JAMA : the journal of the American Medical Association (1986)
 
Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice (with J. Vaage), Journal of the National Cancer Institute (1983)

Tumor-free inbred female C3H/He mice were given weekly injections of cyclophosphamide to prevent or delay...

 

PDF

Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma (with J. Vaage), Cancer research (1979)

Changes in susceptibility to treatment with Cytoxan, methotrexate, 5-fluorouracil, and Adriamycin, single or in combination,...

 
Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Letter: Chemotherapy of breast cancer, The New England journal of medicine (1976)
 
Sounding Board. The problem of breast-cancer prophylaxis, The New England journal of medicine (1975)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Transplantation, Heterologous

Predictive testing with the subrenal capsule assay (with A. E. Bogden, W. Griffin, S. D. Reich, and W. R. Cobb), Cancer treatment reviews (1984)

Measurement of drug activity as an oncolytic effect, use of the control only to monitor...

 
Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update (with A. E. Bogden, S. D. Reich, T. W. Griffin, and W. R. Cobb), Breast cancer research and treatment (1983)

Feasibility of utilizing the 6-day subrenal capsule (SRC) assay to screen drugs against fresh surgical...

 

Triazenes

Results with methyl-CCNU and DTIC in metastatic melanoma (with L. Nathanson, D. Schoenfeld, J. Wolter, J. Colsky, W. Regelson, T. Cunningham, and N. Sedransk), Cancer (1977)

This report is the result of an Eastern Cooperative Oncology Group (ECOG) study. Four hundred...

 
Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma (with L. Nathanson, W. G. Costello, J. Wolter, S. F. Brunk, J. Colsky, T. Hall, R. A. Oberfield, and W. Regelson), Cancer (1976)

This prospective randomized Eastern Cooperative Oncology Group (ECOG) study (1071) was designed to compare a...

 
Letter: Treatment of malignant melanoma (with L. Nathanson), Lancet (1974)
 
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea (with L. Nathanson, R. Lenhard, J. Wolter, J. Colsky, R. A. Oberfield, and A. Schilling), Cancer (1972)
 

Trimetrexate

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642 (with R. B. Weiss, I. C. Henderson, L. Norton, D. A. Berry, C. Cirrincione, E. Winer, W. C. Wood, E. Frei 3rd, O. R. McIntyre, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1999)

PURPOSE: We undertook a prospective, randomized phase III trial to evaluate the safety and efficacy...

 
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study (with N. A. Dawson, A. H. Korzun, G. H. Clamon, M. Pollak, N. J. Vogelzang, R. W. Carey, and L. Norton), Medical and pediatric oncology (1991)

Twenty-two patients with previously untreated metastatic breast cancer and nineteen patients with refractory metastatic breast...

 
Hypersensitivity reactions to trimetrexate (with J. L. Grem, S. A. King, and T. D. Brown), Investigational new drugs (1990)

Trimetrexate is a nonclassical antifol currently being tested for efficacy in cancer patients and as...

 

United States

CDC-funded intervention research aimed at promoting colorectal cancer screening in communities (with Steven S. Coughlin, Maria E. Fernandez, Karen Glanz, Judith W. Lee, Selina A. Smith, Leonardo Stroud, Irene Tessaro, John M. Westfall, Joel L. Weissfeld, and Daniel S. Blumenthal), Cancer (2006)

BACKGROUND: Although strong scientific evidence has shown that screening for colorectal cancer saves lives, most...

 
Applying a stage model of behavior change to colon cancer screening (with Roger Luckmann, Anne M. Stoddard, Jill S. Avrunin, Mary Jo White, Jennifer Rider Stark, Lynn Clemow, and Milagros C. Rosal), Preventive medicine (2005)

BACKGROUND: There has been limited use of stages of change models in characterizing colorectal cancer...

 
Effectiveness of telephone counseling for mammography: results from five randomized trials (with Anne M. Stoddard, Sarah A. Fox, Dorothy S. Lane, M. Robyn Andersen, Nicole Urban, Isaac Lipkus, and Barbara K. Rimer), Preventive medicine (2001)

BACKGROUND: Women over age 50 continue to be underscreened for breast cancer. The purpose of...

 
Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium (with Anne M. Stoddard, Barbara K. Rimer, Dorothy S. Lane, Sarah A. Fox, Isaac Lipkus, Roger Luckmann, Jill S. Avrunin, S. Sprachman, and Nicole Urban), Preventive medicine (1998)

BACKGROUND: The purpose of this report is to describe the characteristics of women ages 50...

 
The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium (with N. Breen, E. J. Feuer, S. Depuy, and Jane G. Zapka), Public health reports (Washington, D.C. : 1974) (1997)

OBJECTIVE: In January 1991, Medicare extended its mammography benefit to reimburse for breast cancer screening...

 
American Cancer Society guidelines for the early detection of breast cancer: update 1997 (with A. M. Leitch, G. D. Dodd, M. Linver, P. Pressman, L. McGinnis, and R. A. Smith), CA: a cancer journal for clinicians (1997)

The American Cancer Society (ACS) convened a workshop in March 1997 to consider new scientific...

 
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study (with M. J. Ratain, G. Rosner, S. L. Allen, D. A. Van Echo, I. C. Henderson, and R. L. Schilsky), Journal of clinical oncology : official journal of the American Society of Clinical Oncology (1995)

PURPOSE: To determine if variability in toxicity of amonafide during phase II trials could be...

 
Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium (with E. A. Coleman and E. J. Feuer), Annals of internal medicine (1992)

OBJECTIVE: To compare breast cancer screening rates from the 1991 survey with data from 1987-88...

 
Breast cancer screening in older women. Synopsis of a forum, Cancer (1992)

There have been no consistent breast cancer screening guidelines for women 65 years of age...

 
Guidelines for breast cancer screening (with S. Shapiro, C. R. Smart, D. E. Henson, A. I. Holleb, R. V. Hutter, B. Krammer, H. D. Kushner, R. McLelland, and M. Moskowitz), Cancer (1992)
 
Validity and reliability of psychosocial factors related to breast cancer screening (with Jane G. Zapka, D. R. Harris, and Anne M. Stoddard), Evaluation and the health professions (1991)

This research explored the construct validity of hypothesized survey items and data reduction procedures for...

 

Urban Population

PDF

Changes in mammography use: economic, need, and service factors (with Jane G. Zapka, David W. Hosmer, Donald R. Harris, and Anne M. Stoddard), American journal of public health (1992)

OBJECTIVES. The purpose of this study was to document changes in mammography use between 1987...

 
The risk factors of age and family history and their relationship to screening mammography utilization (with Anne M. Stoddard, Victoria P. Gaw, and Jane G. Zapka), Journal of the American Geriatrics Society (1992)

OBJECTIVE: To study the association of two well known risk factors for breast cancer and...

 

Vasoactive Intestinal Peptide

Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses (with R. F. Gagel, R. A. DeLellis, R. A. Norton, S. R. Bloom, H. H. Miller, A. Ucci, and L. Nathanson), Archives of internal medicine (1976)

A patient with watery diarrhea, hypokalemia, hypochlorhydria, and a non-beta islet cell carcinoma of the...

 

Vincristine

Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glimoa (with M. Buechler, J. Munzenreider, B. Emami, B. Mukherji, W. Shucart, M. Scott, L. Nathanson, R. Rudders, B. Stein, K. Post, and A. Piro), International journal of radiation oncology, biology, physics (1979)
 

Virus Diseases

Carcinofetal antigens (with L. Nathanson), Progress in clinical immunology (1974)
 

Washington

Confirmatory analysis of opinions regarding the pros and cons of mammography (with W. Rakowski, M. Robyn Andersen, Anne M. Stoddard, Nicole Urban, Barbara K. Rimer, Dorothy S. Lane, and Sarah A. Fox), Health psychology : official journal of the Division of Health Psychology, American Psychological Association (1997)

This investigation extends prior research to apply decision-making constructs from the transtheoretical model (TTM) of...